Correlation Between RenovoRx and Humacyte
Can any of the company-specific risk be diversified away by investing in both RenovoRx and Humacyte at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining RenovoRx and Humacyte into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between RenovoRx and Humacyte, you can compare the effects of market volatilities on RenovoRx and Humacyte and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in RenovoRx with a short position of Humacyte. Check out your portfolio center. Please also check ongoing floating volatility patterns of RenovoRx and Humacyte.
Diversification Opportunities for RenovoRx and Humacyte
Very good diversification
The 3 months correlation between RenovoRx and Humacyte is -0.49. Overlapping area represents the amount of risk that can be diversified away by holding RenovoRx and Humacyte in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Humacyte and RenovoRx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on RenovoRx are associated (or correlated) with Humacyte. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Humacyte has no effect on the direction of RenovoRx i.e., RenovoRx and Humacyte go up and down completely randomly.
Pair Corralation between RenovoRx and Humacyte
Given the investment horizon of 90 days RenovoRx is expected to generate 1.02 times more return on investment than Humacyte. However, RenovoRx is 1.02 times more volatile than Humacyte. It trades about 0.11 of its potential returns per unit of risk. Humacyte is currently generating about -0.08 per unit of risk. If you would invest 103.00 in RenovoRx on August 29, 2024 and sell it today you would earn a total of 33.00 from holding RenovoRx or generate 32.04% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
RenovoRx vs. Humacyte
Performance |
| Timeline |
| RenovoRx |
| Humacyte |
RenovoRx and Humacyte Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with RenovoRx and Humacyte
The main advantage of trading using opposite RenovoRx and Humacyte positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if RenovoRx position performs unexpectedly, Humacyte can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Humacyte will offset losses from the drop in Humacyte's long position.| RenovoRx vs. Adial Pharmaceuticals | RenovoRx vs. Pasithea Therapeutics Corp | RenovoRx vs. Quoin Pharmaceuticals Ltd | RenovoRx vs. Nutriband |
| Humacyte vs. Crinetics Pharmaceuticals | Humacyte vs. Viridian Therapeutics | Humacyte vs. Cytokinetics | Humacyte vs. Structure Therapeutics American |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Other Complementary Tools
| CEOs Directory Screen CEOs from public companies around the world | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |